Advertisement
Advertisement

Memantine And Donepezil Latest News

Get the latest updates on this drug from the GoodRx medical team

New Alzheimer’s Med Namzaric Approved

The GoodRx Pharmacist - January 13, 2015

Namzaric (memantine/donepezil) is a new combination drug approved on December 24, 2014 for the treatment of moderate to severe dementia of the Alzheimer type (Alzheimer’s disease) in patients already taking Namenda XR (memantine) and Aricept (donepezil).

What is Alzheimer’s disease?

Alzheimer’s disease involves a decline in mental ability that is severe enough to affect daily activities. It is a progressive disease that follows three stages: mild, moderate, and severe. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.